{"product_id":"hfsa-ahftc-board-certification-review-2024","title":"HFSA AHFTC Board Certification Review 2024","description":"The HFSA AHFTC Board Certification Review 2024 is now available OnDemand in the HFSA Learning Center! This product is ideal for healthcare providers seeking a comprehensive and high-quality overview of heart failure, especially those preparing for the ABIM AHFTC certification exams in November 2024.\u003cbr\u003e\u003ch3\u003eWhy Choose OnDemand Access?\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eFlexible Learning:\u003c\/strong\u003e Enjoy the freedom to access recorded presentations, slide decks, and essential attendee resources at your own pace. Whether you’re preparing for the upcoming ABIM AHFTC examinations or looking to deepen your expertise, our OnDemand course adapts to your busy schedule.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComprehensive Content:\u003c\/strong\u003e Gain insights from a wide range of topics presented by leading experts, based on the ABIM AHFTC blueprint. Our OnDemand product includes:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAccess to 13 pre-recorded presentations and full recordings of the live sessions, with the option to watch at 2x speed for efficient learning.\u003c\/li\u003e\n\u003cli\u003eDownloadable slide decks for reference and review.\u003c\/li\u003e\n\u003cli\u003eExclusive attendee resources, including the Question Bank and reading list.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003ePROGRAM\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eDAY 1 (FRI 07\/12\/2024)\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e08:30 am – 08:45 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eWelcome and HFSA Introduction\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eNancy Sweitzer, MD, PhD, FHFSA and Maria Rosa Costanzo, MD, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e08:45 am – 09:15 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eLive ABIM Style Question Session\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eNancy Sweitzer, MD, PhD, FHFSA and Maria Rosa Costanzo, MD, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e09:15 am – 09:45 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eHemodynamics in HF II\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eJames C. Fang, MD, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e09:45 am – 10:15 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eOptimal Medical Therapy for HFrEF 1\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eMark Drazner, MD, MSc, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e10:15 am – 10:45 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eOptimal Medical Therapy for HFrEF 2\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eMark Drazner, MD, MSc, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e10:45 am – 11:00 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eREFRESHMENT BREAK\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e11:00 am – 11:30 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eCardio Renal Failure Interactions in Heart Failure\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e11:30 am – 12:00 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eAssessment of Functional Capacity Including Cardiopulmonary Exercise Testing\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eGregory Lewis, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e12:00 pm – 12:30 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eQ\u0026amp;A – Faculty\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e12:30 pm – 01:30 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eLUNCH\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e01:30 pm – 02:00 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eHFpEF: Epidemiology, Risk Factors, Diagnosis, Management (For the Boards)\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eSanjiv Shah, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e02:00 pm – 02:30 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eManagement of Comorbidities in Heart Failure: Iron Deficiency\/Anemia\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eGregory Lewis, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e02:30 pm – 03:00 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003ePulmonary Hypertension: Classification and Initial Evaluation\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eJonathan Rich, MD, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e03:00 pm – 03:30 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003ePulmonary Hypertension: Treatment\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eJonathan Rich, MD, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e03:30 pm – 03:45 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eREFRESHMENT BREAK\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e03:45 pm – 04:15 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eSpecific Etiologies of HF 1: HCM\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eJane Wilcox, MD, MSc, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e04:15 pm – 04:45 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eSpecific Etiologies of HF 2: Other Inherited HF syndromes\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eJane Wilcox, MD, MSc, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e04:45 pm – 05:15 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eSpecific Etiologies of HF 3: Infiltrative Disorders and Restrictive CMP\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eSanjiv Shah, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e05:15 pm – 05:45 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eQ\u0026amp;A – Faculty\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eDAY 2  (FRI 08\/12\/2024)\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e08:00 am – 08:15 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eWelcome \u0026amp; HFSA Introduction, Practice Question\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eNancy Sweitzer, MD, PhD, FHFSA and Maria Rosa Costanzo, MD, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e08:15 am – 08:45 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eSpecific Etiologies of HF 4: Myocarditis and Inflammatory Cardiomyopathies\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eMaria Rosa Costanzo, MD, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e08:45 am – 09:15 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eManagement of the Hospitalized HF Patient\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eMaria Rosa Costanzo, MD, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e09:15 am – 09:45 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eAdvanced Heart Failure: Defining the Phenotype and Patient Selection for Advanced Therapies\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eNancy Sweitzer, MD, PhD, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e09:45 am – 10:00 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eREFRESHMENT BREAK\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e10:00 am – 10:30 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eImmunology: The Basics, PRA, Sensitization, Crossmatch\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eSean Pinney, MD, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e10:30 am – 11:00 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eRejection: Cellular and Antibody Mediated\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eSean Pinney, MD, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e11:00 am – 11:30 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eHeart Transplant, Clinical Outcomes and Complications\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eMichelle Kittleson, MD, PhD, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e11:30 am – 12:00 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eManaging Immunosuppression and Drugs\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eMichelle Kittleson, MD, PhD, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e12:00 pm – 01:00 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eWorking Lunch\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e01:00 pm – 01:30 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003ePregnancy in HF\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eKathryn Lindley, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e01:30 pm – 02:00 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eCardiogenic Shock Management\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eNancy Sweitzer, MD, PhD, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e02:00 pm – 02:30 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eMCS 1: Durable MCS Devices and Outcomes\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eJoseph G. Rogers, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e02:30 pm – 02:45 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eREFRESHMENT BREAK\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e02:45 pm – 03:15 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eMCS 2: Temporary Support Devices and ECMO for the Boards\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eManreet Kanwar, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e03:15 pm – 03:45 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eMCS 3: Management of Complications of MCS\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eManreet Kanwar, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e03:45 pm – 05:15 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eMCS 4: Interactive Shock and Device Management\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eDaniel Burkhoff, MD, PhD, Manreet Kanwar, MD, Joseph G. Rogers, MD, and Nancy Sweitzer, MD, PhD, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e05:15 pm – 05:45 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eQ\u0026amp;A – Faculty\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e08:00 am – 08:15 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eWelcome \u0026amp; HFSA Introduction, Practice Question\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eNancy Sweitzer, MD, PhD, FHFSA and Maria Rosa Costanzo, MD, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e08:15 am – 08:45 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eAdult Congenital Heart Disease for the HF Specialist\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eEric V. Krieger, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e08:45 am – 09:15 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eManagement of Left Sided Valvular Heart Disease in Heart Failure\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eJane Wilcox, MD, MSc, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e09:15 am – 09:45 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eManagement of Common Arrhythmias 1: Atrial Fibrillation and Flutter\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eRoderick Tung, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e09:45 am – 10:15 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eManagement of Common Arrhythmias 2: Ventricular Arrhythmia\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eRoderick Tung, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e10:15 am – 10:30 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eREFRESHMENT BREAK\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e10:30 am – 11:00 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eDevice Therapy in Heart Failure I: Sudden Death Prevention\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eChristine Albert, MD, MPH\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e11:00 am – 11:30 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eDevice Therapy in Heart Failure II: CRT\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eChristine Albert, MD, MPH\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e11:30 am – 12:00 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eQ\u0026amp;A – Faculty\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eDAY 3 (FRI 09\/12\/2024)\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e08:00 am – 08:15 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eWelcome \u0026amp; HFSA Introduction, Practice Question\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eNancy Sweitzer, MD, PhD, FHFSA and Maria Rosa Costanzo, MD, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e08:15 am – 08:45 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eAdult Congenital Heart Disease for the HF Specialist\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eEric V. Krieger, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e08:45 am – 09:15 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eManagement of Left Sided Valvular Heart Disease in Heart Failure\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eJane Wilcox, MD, MSc, FHFSA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e09:15 am – 09:45 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eManagement of Common Arrhythmias 1: Atrial Fibrillation and Flutter\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eRoderick Tung, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e09:45 am – 10:15 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eManagement of Common Arrhythmias 2: Ventricular Arrhythmia\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eRoderick Tung, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e10:15 am – 10:30 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eREFRESHMENT BREAK\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e10:30 am – 11:00 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eDevice Therapy in Heart Failure I: Sudden Death Prevention\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eChristine Albert, MD, MPH\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e11:00 am – 11:30 am\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eDevice Therapy in Heart Failure II: CRT\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eChristine Albert, MD, MPH\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e11:30 am – 12:00 pm\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eQ\u0026amp;A – Faculty\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954417176674,"sku":"MED-AMB03132","price":120.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/HFSA-AHFTC-Board-Certification-Review-2024.jpg?v=1779375996","url":"https:\/\/meducourse.com\/products\/hfsa-ahftc-board-certification-review-2024","provider":"Meducourse","version":"1.0","type":"link"}